When Brands Complement Patents in Securing the Returns from Technological Innovation: The Case of Bayer Aspirin

Klaus Jennewein; Thomas Durand; Alexander Gerybadze

doi:10.7202/044294ar

Journal Articles Management international Year : 2010

When Brands Complement Patents in Securing the Returns from Technological Innovation: The Case of Bayer Aspirin

(1) , (2, 3) , (4)

1
2
3
4

Klaus Jennewein

Function : Author

Deutsche Telekom Laboratories

Thomas Durand

Function : Author
PersonId : 174836
IdHAL : thomas-durand
IdRef : 168605473

Conservatoire National des Arts et Métiers [CNAM]

Ecole Centrale Paris

Alexander Gerybadze

Function : Author

Universität Hohenheim

Domains

Humanities and Social Sciences Humanities and Social Sciences Business administration

Thomas Durand : Connect in order to contact the contributor

https://hal-cnam.archives-ouvertes.fr/hal-02122742

Submitted on : Tuesday, May 7, 2019-3:03:04 PM

Last modification on : Wednesday, September 28, 2022-5:56:36 AM

Dates and versions

hal-02122742 , version 1 (07-05-2019)

Identifiers

HAL Id : hal-02122742 , version 1
DOI : 10.7202/044294ar

Cite

Klaus Jennewein, Thomas Durand, Alexander Gerybadze. When Brands Complement Patents in Securing the Returns from Technological Innovation: The Case of Bayer Aspirin. Management international, 2010, 14 (3), pp.73. ⟨10.7202/044294ar⟩. ⟨hal-02122742⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

EC-PARIS CNAM

110 View

0 Download

When Brands Complement Patents in Securing the Returns from Technological Innovation: The Case of Bayer Aspirin

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share